ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Michael - Transplanting blood stem cells

Patient basic information Patient: Mr. Michael Miller) Nationality: Cyprus Diagnosis: Transplantation of blood stem cells Clinical hospital: H0ZH Treatment: Internal therapy + medication Holidays: 53 days Treatment cost: about 948308 yuan Treatment effect: Functional recovery The patient is from Cyprus and was diagnosed locally as having a blood stem cell transplant. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, guidance and on-site services throughout the treatment process.

After 153 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the standard of discharge. Treatment results: the patient's final functional recovery. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track the recovery through a remote follow-up system.

'Mr. Michael Liu has criticized the case as a typical case of cross-border suspected seriousness clinical disease. The multi-disciplinary collaboration mechanism for the development of intracellular therapy+ drug programs for blood stem cell transplantation demonstrates the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated.

塞浦路斯,造血干细胞移植,浙江大学医学院附属第二医院,国际医疗,来华就医,中国医疗